News details

 
Information title

ImClone builds case for higher takeover bid

Published on Thursday 28 August 2008 - 17:40

Summary :
The executives at ImClone have been carefully crunching the numbers for both its pipeline drugs as well as Erbitux as it builds a case that Bristol-Myers Squibb's current offer is far too low to...
Read more

Information source

http://www.fiercebiotech.com/news/frontpage

Website description
Get the latest news on the biotech industry, biotech companies, FDA approval and clinical research. Sign up today for the biotech industry

Articles published on this website : 1 / 7 days - 3 / 30 days

Takeda dumps GVAX partnership Infinity gets $75M for cancer partnership Ganymed gains $82M in new round Predictive Biosciences raises $21.75M in Series B Cell Genesys halts GVAX program, cuts jobs

Other articles published on other websites on the same day

Hormone Therapy May Speed Prostate Cancer http://www.webmd.com/ Prostate Cancer Screening and Prevention: A Clinical Update for Primary Care Providers http://www.medscape.com/ Cell Genesys Stops Trial For Cancer Vaccine After Deaths http://www.dbtechno.com/ Oilers take aim at prostate cancer http://slam.canoe.ca/ Indian, Pakistani immigrants to the US face prostate, breast cancer risks http://www.dailyindia.com/ Free prostate cancer exams offered http://www.thesunchronicle.com/ Health risk behaviors such as smoking and obesity associated with lower prostate specific antigen awareness http://www.news-medical.net/ Levitra effective on demand http://www.upi.com/ Prostate cancer experts to speak http://www.theacorn.com/